Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer

Lung cancer is the leading cause of cancer-related deaths in the United States with non-small cell lung cancer (NSCLC) accounting for most cases. Despite advances in cancer therapeutics, the 5-year survival rate has remained poor due to several contributing factors, including its resistance to thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Ga-Ram, Yuen, John G., Fesler, Andrew, Farley, Hannah, Haley, John D., Ju, Jingfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995506/
https://www.ncbi.nlm.nih.gov/pubmed/36911069
http://dx.doi.org/10.1016/j.omto.2023.02.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995506/
https://www.ncbi.nlm.nih.gov/pubmed/36911069
http://dx.doi.org/10.1016/j.omto.2023.02.007

Ejemplares similares